#obesity-management

[ follow ]
#glp-1-receptor-agonists

Enormous potential': weight-loss drugs cut cancer risk by a fifth, research shows

Weight-loss drugs can reduce the risk of developing certain types of cancers and improve long-term survival rates.

Obesity surgery in the time of Ozempic: They are not two competing treatments, but rather complementary ones'

Innovative anti-obesity drugs are transforming obesity treatment and affecting the role of bariatric surgery.

Enormous potential': weight-loss drugs cut cancer risk by a fifth, research shows

Weight-loss drugs can reduce the risk of developing certain types of cancers and improve long-term survival rates.

Obesity surgery in the time of Ozempic: They are not two competing treatments, but rather complementary ones'

Innovative anti-obesity drugs are transforming obesity treatment and affecting the role of bariatric surgery.
moreglp-1-receptor-agonists

Ilant Health Raises Another $2.5M for its Value-Based Care Platform for Obesity Management

Obesity affects 42% of Americans, costing $1.76T annually; value-based care is crucial for prevention.

New study suggests strategies for keeping off pounds

Regular weighing and planning for possible setbacks can help maintain weight loss.
Specific strategies post-weight loss can slow weight regain and benefit obese adults.

Doctors Surprised When Patients Who Start Semaglutide Are Frequently Cured of Other Conditions

Weight loss drugs like Wegovy and Zepbound may have secondary benefits in improving chronic conditions like arthritis according to medical practitioners.
[ Load more ]